VentureMed Group
Plymouth, Minnesota, United States · Healthcare, Health Care · 32 employees
VentureMed Group, Inc. is a pioneering privately held medical device company based in Minnesota dedicated to advancing endovascular solutions for arteriovenous (AV) access and peripheral vascular disease interventions. The company's flagship technology, the FLEX Vessel Prep™ System, is an FDA 510(k)-cleared and CE Mark-approved device, that is designed to optimize vessel preparation using its prop
Funding history
- Funding Round — $49.2M — Oct 2025
- Series SERIES C — $28.0M — Oct 2025
- Funding Round — $7.0M — Feb 2025
- Series seed — $7.0M — Nov 2024
Recent signals
- Feb 11, 2026: VentureMed Group Appoints Bruce Fiedler as Chief Financial Officer
- Oct 31, 2025: Raised $49.2M
- Oct 29, 2025: Raised $28.0M in Series SERIES C
- Mar 12, 2025: VentureMed Group Expands Commercial Leadership Team to Accelerate Growth
- Feb 12, 2025: Raised $7.0M
- Nov 12, 2024: Raised $7.0M in Series seed
See plans & pricing → Track VentureMed Group’s funding, hiring, and signals — with verified contacts — on Fundz.